［1］HU C,XUAN Y,ZHANG X,et al.Immune cell metabolism and metabolic reprogramming［J］.Mol Biol Rep,2022,49:9783-9795.
［2］ROSTAMIAN H,KHAKPOOR-KOOSHEH M,JAFARZADEH L,et al.Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions［J］.BMC Cancer,2022,22(1):39.
［3］LEONE RD,POWELL JD.Metabolism of immune cells in cancer［J］.Nat Rev Cancer,2020,20(9):516-531.
［4］BECKERMANN KE,DUDZINSKI SO,RATHMELL JC.Dysfunctional T cell metabolism in the tumor microenvironment［J］.Cytokine Growth Factor Rev,2017,35:7-14.
［5］DEY P,KIMMELMAN AC,DEPINHO RA.Metabolic codependencies in the tumor microenvironment［J］.Cancer Discov,2021,11(5):1067-1081.
［6］YANG T,YAN X,CAO Y,et al.Meta-analysis of glutamine on immune function and post-operative complications of patients with colorectal cancer［J］.Front Nutr,2021,8:765809.
［7］JOHNSON MO,WOLF MM,MADDEN MZ,et al.Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism［J］.Cell,2018,175(7):1780-1795.
［8］FU Q,XU L,WANG Y,et al.Tumor-associated macrophage-derived interleukin-23 interlinks kidney cancer glutamine addiction with immune evasion［J］.Eur Urol,2019,75(5):752-763.
［9］EDWARDS DN,NGWA VM,RAYBUCK AL,et al.Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer［J］.J Clin Invest,2021,131(4):e140100.
［10］LEONE RD,ZHAO L,ENGLERT JM,et al.Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion［J］.Science,2019,366(6468):1013-1021.
［11］HUANG M,XIONG D,PAN J,et al.Targeting glutamine metabolism to enhance immunoprevention of EGFR-driven lung cancer［J］.Adv Sci (Weinh),2022,9(26):e2105885.
［12］WATSON MJ,VIGNALI P,MULLETT SJ,et al.Metabolic support of tumour-infiltrating regulatory T cells by lactic acid［J］.Nature,2021,591(7851):645-651.
［13］WANG L,WU Q,LIU J,et al.Lactic acid inhibits iNKT cell functions via a phosphodiesterase-5 dependent pathway［J］.Biochem Biophys Res Commun,2021,547:9-14.
［14］GU J,ZHOU J,CHEN Q,et al.Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cells［J］.Cell Rep,2022,39(12):110986.
［15］FENG Q,LIU Z,YU X,et al.Lactate increases stemness of CD8+T cells to augment anti-tumor immunity［J］.Nat Commun,2022,13(1):4981.
［16］PEREZ-CASTRO L,GARCIA R,VENKATESWARAN N,et al.Tryptophan and its metabolites in normal physiology and cancer etiology［J］.FEBS J,2021,10:16245.
［17］DING X,BIN P,WU W,et al.Tryptophan metabolism,regulatory T cells, and inflammatory bowel disease:A mini review［J］.Mediators Inflamm,2020,3(2020):9706140.
［18］GOLD LT,MASSON GR.GCN2:roles in tumour development and progression［J］.Biochem Soc Trans,2022,50(2):737-745.
［19］QIN R,ZHAO C,WANG CJ,et al.Tryptophan potentiates CD8(+) T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation［J］.J Immunother Cancer,2021,9(7):e002840.
［20］GOETZMAN ES,PROCHOWNIK EV.The role for Myc in coordinating glycolysis,oxidative phosphorylation,glutaminolysis,and fatty acid metabolism in normal and neoplastic tissues［J］.Front Endocrinol (Lausanne),2018,9:129.
［21］YOSHIDA GJ.Beyond the warburg effect:N-Myc contributes to metabolic reprogramming in cancer cells［J］.Front Oncol,2020,10:791.
［22］LIU YN,YANG JF,HUANG DJ,et al.Hypoxia induces mitochondrial defect that promotes t cell exhaustion in tumor microenvironment through MYC-regulated pathways［J］.Front Immunol,2020,11:1906.
［23］LI J,PAN J,LIU Y,et al.3-Bromopyruvic acid regulates glucose metabolism by targeting the c-Myc/TXNIP axis and induces mitochondria-mediated apoptosis in TNBC cells［J］.Exp Ther Med,2022,24(2):520.
［24］DANG EV,BARBI J,YANG HY,et al.Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1［J］.Cell,2011,146(5):772-784.
［25］LIU X,LIU L,CHEN K,et al.Huaier shows anti-cancer activities by inhibition of cell growth,migration and energy metabolism in lung cancer through PI3K/AKT/HIF-1α pathway［J］.J Cell Mol Med,2021,25(4):2228-2237.
［26］HUANG YY,JIANG HX,SHI QY,et al.miR-145 inhibits th9 cell differentiation by suppressing activation of the PI3K/AKT/mTOR/p70S6K/HIF-1α pathway in malignant ascites from liver cancer［J］.Onco Targets Ther,2020,13:3789-3800.
［27］XIA L,SUN J,XIE S,et al.PRKAR2B-HIF-1α loop promotes aerobic glycolysis and tumour growth in prostate cancer［J］.Cell Prolif,2020,53(11):e12918.
［28］XU K,YIN N,PENG M,et al.Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity［J］.Science,2021,371(6527):405-410.
［29］HAJJAR S,NATHAN N,JOSEPH J,et al.Foxo3a tempers excessive glutaminolysis in activated T cells to prevent fatal gut inflammation in the murine IL-10(-/-) model of colitis［J］.Cell Death Differ,2022,29(3):585-599.
［30］ZHANG H,ZHANG Y,PAN J,et al.iNKT subsets differ in their developmental and functional requirements on Foxo1［J］.Proc Natl Acad Sci USA,2021,118(46):e2105950118.
［31］BI E,MA X,LU Y,et al.Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T(H)9 cells programmed by IL-7［J］.Sci Signal,2017,10(500):e9741.
［32］QIU W,WANG B,GAO Y,et al.Targeting histone deacetylase 6 reprograms interleukin-17-producing helper T cell pathogenicity and facilitates immunotherapies for hepatocellular carcinoma［J］.Hepatology,2020,71(6):1967-1987.
［33］YAN Y,ZHOU XE,XU HE,et al.Structure and physiological regulation of AMPK［J］.Int J Mol Sci,2018,19(11):3543.
［34］HE J,SHANGGUAN X,ZHOU W,et al.Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development［J］.Nat Commun,2021,12(1):4371.
［35］LI Y,LI G,ZHANG J,et al.The dual roles of human γδ T cells:Anti-tumor or tumor-promoting［J］.Front Immunol,2020,11:619954.
［36］HARLY C,JOYCE SP,DOMBLIDES C,et al.Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2［J］.Sci Immunol,2021,6(61):e9010.
［37］XU W,WU Y,WANG L,et al.Autoantibody against β(1)-adrenoceptor promotes the differentiation of natural regulatory T cells from activated CD4(+) T cells by up-regulating AMPK-mediated fatty acid oxidation［J］.Cell Death Dis,2019,10(3):158.
［38］GAO Y,PIVINEN P,TRIPATHI S,et al.Inactivation of AMPK leads to attenuation of antigen presentation and immune evasion in lung adenocarcinoma［J］.Clin Cancer Res,2022,28(1):227-237.
［39］POKHREL RH,ACHARYA S,AHN JH,et al.AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway［J］.Mol Cancer,2021,20(1):133.
［40］TIMILSHINA M,YOU Z,LACHER SM,et al.Activation of mevalonate pathway via LKB1 is essential for stability of T(reg) cells［J］.Cell Rep,2019,27(10):2948-2961.
［41］BAIXAULI F,PILETIC K,PULESTON DJ,et al.An LKB1-mitochondria axis controls T(H)17 effector function［J］.Nature,2022,610(7932):555-561.
［42］PANDIT M,TIMILSHINA M,CHANG JH.LKB1-PTEN axis controls Th1 and Th17 cell differentiation via regulating mTORC1［J］.J Mol Med (Berl),2021,99(8):1139-1150.
［43］PONS-TOSTIVINT E,LUGAT A,FONTENAU JF,et al.STK11/LKB1 modulation of the immune response in lung cancer:From biology to therapeutic impact［J］.Cells,2021,10(11):3129.
［44］BEST SA,GUBSER PM,SETHUMADHAVAN S,et al.Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer［J］.Cell Metab,2022,34(6):874-887.
［45］WAICKMAN AT,POWELL JD.mTOR,metabolism,and the regulation of T-cell differentiation and function［J］.Immunol Rev,2012,249(1):43-58.
［46］ZHAO R,SONG Y,WANG Y,et al.PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/AKT/mTOR signalling pathway［J］.Cell Prolif,2019,52(3):e12571.
［47］LIU X,YIN M,DONG J,et al.Tubeimoside-1 induces TFEB-dependent lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting mTOR［J］.Acta Pharm Sin B,2021,11(10):3134-3149.
［48］LIU X,ZHAO Y,WU X,et al.A novel strategy to fuel cancer immunotherapy:targeting glucose metabolism to remodel the tumor microenvironment［J］.Front Oncol,2022,12:931104.